(pressebox) Langenfeld, 11.05.2009, ARTES Biotechnology GmbH today announces the collaboration with Henkel in a joint three years research program that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims at the development and manufacturing of peptides with adhesive properties.
ARTES will apply its proprietary technology platforms – the yeast expression technologies Hansenula and Arxula and the Chaperone technology for improved secretion. The generation of production cell lines, analytical assay development, and lab-scale fermentation/down stream process development are ARTES’ responsibilities in this cooperation. Innovative strategies for the production of difficult-to-express adhesive peptides shall be developed, resulting in next generation tools for ARTES’ contract R&D.Über ARTES Biotechnology GmbH
ARTES is a Germany-based biotechnology company specialized in recombinant protein production from yeast expression systems. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha and Arxula adeninivorans. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld near Duesseldorf. The company is a strategic partner for the chemical and pharmaceutical industry, developing cost-efficient production processes for internationally marketed products on a contract R&D basis.
No Comments on "ARTES enters into a partnership with Henkel in a 3-year research program"